Cam Gallagher, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 14,117 shares at $50.16 ($708K) on 2022-02-14, disclosed to the SEC on 2022-02-14.
Open-market sale of $708k ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.16 | 2,079 | $104K | 14.7% |
| 2 | $50.16 | 2,079 | $104K | 14.7% |
| 3 | $50.17 | 4,850 | $243K | 34.4% |
| 4 | $50.17 | 4,850 | $243K | 34.4% |
| 5 | $50.75 | 259 | $13K | 1.9% |
| Total | $50.18 avg | 14,117 |
| $708K |
| 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |